Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GUBRA.COthis companyGubra A/S	DKK 310.60	4.98×	7.35×	3.2×	3.81×	241.4%	96.7%	84.2%	64.1%	147.5%	139.0%	20.1%	0.09×	0.03×	204.42×	13.63×	11.9%	2	13.48	2	C+
BAVA.COBavarian Nordic A/S	DKK 246.80	10.83×	1.16×	2.41×	8.14×	-689.9%	47.4%	14.9%	22.3%	10.7%	5.2%	9.2%	0.01×	-0.97×	70.08×	4.22×	0.0%	7	9.87	5	A+
GMAB.COGenmab A/S	DKK 3,661.00	126.06×	21.59×	32.64×	94.9×	-90.7%	91.7%	33.6%	25.9%	17.1%	8.9%	0.9%	0.95×	2.8×	20.49×	2.02×	0.0%	6	22.57	2	C+
HLUN-B.COH. Lundbeck A/S	DKK 56.20	13.4×	1.72×	1.76×	7×	437.7%	79.6%	26.0%	13.1%	12.8%	10.0%	10.1%	0.48×	1.17×	11.72×	1.44×	2.2%	7	2.62	4	A
NOVO-B.CONovo Nordisk A/S	DKK 272.80	14.1×	7.45×	4.68×	10.37×	-15.8%	81.0%	41.3%	33.1%	52.8%	29.5%	2.0%	0.67×	0.7×	18.83×	0.8×	3.6%	6	3.77	4	A-
ZEAL.COZealand Pharma A/S	DKK 245.00	5.09×	2.22×	3.57×	4×	-647.0%	99.7%	77.7%	70.0%	43.5%	41.7%	19.8%	0.03×	-0.58×	189.81×	23.57×	0.0%	3	7.44	4	A
Peer median	—	13.4×	2.22×	3.57×	8.14×	-90.7%	81.0%	33.6%	25.9%	17.1%	10.0%	9.2%	0.48×	0.7×	20.49×	2.02×	0.0%	6	7.44	4	—